ASSOCIATION OF THE POLYMORPHIC INTRON 3 16 BP DUPLICATION IN TP53 (RS17878362) WITH A LOW Δ40P53:P53 RATIO AND BETTER OUTCOME IN BREAST CANCER

被引:0
|
作者
Morten, Brianna [1 ,2 ]
Wong-Brown, Michelle [1 ,2 ]
Scott, Rodney [1 ,2 ,3 ]
Avery-Kiejda, Kelly [1 ,2 ]
机构
[1] Hunter Med Res Inst, Ctr Informat Based Med, Sydney, NSW 2305, Australia
[2] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Prior Res Ctr Canc, Callaghan, NSW 2308, Australia
[3] John Hunter Hosp, Pathol North, New Lambton Hts, NSW 2305, Australia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PP27
引用
收藏
页码:13 / 14
页数:2
相关论文
共 50 条
  • [21] Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk
    Rodrigues Laprano, Tatiana Dantas
    Lemos, Erika Hardy
    Pinto Cunha, Lia Moreira
    Eleuterio Junior, Jose
    de SousaTeles, Rosiane Alves
    Barem Rabenhorst, Silvia Helena
    TUMOR BIOLOGY, 2014, 35 (08) : 7435 - 7440
  • [22] Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
    Na, Bing
    Yu, Xin
    Withers, Tracy
    Gilleran, John
    Yao, Ming
    Foo, Tzeh Keong
    Chen, Chunxia
    Moore, Dirk
    Linz, Yong
    Kimball, S. David
    Xia, Bing
    Ganesan, Shridar
    Carpizo, Darren R.
    NPJ BREAST CANCER, 2019, 5 (1)
  • [23] Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
    Na, B.
    Yu, X.
    Wither, T.
    Gilleran, J.
    Yao, M.
    Foo, T. K.
    Chen, C.
    Moore, D.
    Xia, B.
    Lin, Y.
    Kimball, D.
    Ganesan, S.
    Carpizo, D.
    CANCER RESEARCH, 2019, 79 (04)
  • [24] Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
    Bing Na
    Xin Yu
    Tracy Withers
    John Gilleran
    Ming Yao
    Tzeh Keong Foo
    Chunxia Chen
    Dirk Moore
    Yong Lin
    S. David Kimball
    Bing Xia
    Shridar Ganesan
    Darren R. Carpizo
    npj Breast Cancer, 5
  • [25] p53 protein expression affected by TP53 polymorphism is associated with the biological behavior and prognosis of low rectal cancer
    Zhang, Guangzhe
    Xu, Qian
    Wang, Zeyang
    Sun, Liping
    Lv, Zhi
    Liu, Jingwei
    Xing, Chengzhong
    Yuan, Yuan
    ONCOLOGY LETTERS, 2019, 18 (06) : 6807 - 6821
  • [26] Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations
    Hodgson, Anjelica
    Rhijn, Bas W. G. van
    Kim, Sung Sun
    Ding, Colleen
    Saleeb, Rola
    Vesprini, Danny
    Liu, Stanley K.
    Yousef, George M.
    Kwast, Theodorus H. van der
    Xu, Bin
    Downes, Michelle R.
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [27] Combined Immunohistochemistry of PLK1, p21, and p53 for Predicting TP53 Status An Independent Prognostic Factor of Breast Cancer
    Watanabe, Gou
    Ishida, Takanori
    Furuta, Akihiko
    Takahashi, Shin
    Watanabe, Mika
    Nakata, Hideaki
    Kato, Shunsuke
    Ishioka, Chikashi
    Ohuchi, Noriaki
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (08) : 1026 - 1034
  • [28] Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms and their haplotypes in susceptibility to sarcopenia in Iranian older adults
    Montazeri-Najafabady, Nima
    Dabbaghmanesh, Mohammad Hossein
    Nasimi, Nasrin
    Sohrabi, Zahra
    Estedlal, Alireza
    Asmarian, Naeimehossadat
    BMC GERIATRICS, 2022, 22 (01)
  • [29] Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years (vol 12, pg 269, 2002)
    Wang-Gohrke, S
    Becher, H
    Kreienberg, R
    Runnebaum, IB
    Chang-Claude, J
    PHARMACOGENETICS, 2002, 12 (06): : 505 - 505
  • [30] Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms and their haplotypes in susceptibility to sarcopenia in Iranian older adults
    Nima Montazeri-Najafabady
    Mohammad Hossein Dabbaghmanesh
    Nasrin Nasimi
    Zahra Sohrabi
    Alireza Estedlal
    Naeimehossadat Asmarian
    BMC Geriatrics, 22